Related Experiment Video
Updated: Aug 4, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
Expression analysis of Rho GTPase-related lncRNAs in breast cancer
Amir Nicknam1, Sahar Khojasteh Pour2, Mohammad Amin Hashemnejad3
1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
The Rho GTPases have prominent roles in cell cycle transition and cell migration. Some members of this family have been found to be mutated in cancers. Moreover, alterations in expression levels and/or activity of these proteins have been reported in many types of cancers. Thus, Rho GTPases are involved in the carcinogenesis. Rho GTPases regulate growth, motility, invasiveness and metastatic ability of breast cancer cells. Long non-coding RNAs (lncRNAs) have been revealed to exert significant effect in the regulation of these proteins via direct routes or through sequestering microRNAs that inhibit Rho GTPases. We aimed to assess expression levels of four Rho GTPase-related lncRNAs, namely NORAD, RAD51-AS1, NRAV and DANCR in breast cancer samples versus non-cancerous specimens from the same individuals. Expression levels of NORAD were shown to be elevated in tumoral tissues compared with non-tumoral tissues (Expression ratio (95% CI)= 5.85 (3.16-10.83), Standard error of mean (SEM)= 0.44, P value< 0.0001). NRAV expression was also higher in tumoral tissues compared with control tissues (Expression ratio=2.85 (1.52-5.35), SEM= 0.45, P value= 0.0013). Similar to these lncRNAs, RHOA was demonstrated to be up-regulated in malignant tissues (Expression ratio=6.58 (3.17-13.63), SEM= 0.52, P value< 0.0001). Although expression ratio values showed up-regulation of RAD51-AS1 and DANCR in cancerous tissues (Expression ratio (95% CI)= 2.2 (1.05-4.6) and 1.35 (0.72-2.53), respectively), P values did not reach significance level (P values=0.0706 and 0.3746, respectively). There were significant associations between expression level of NRAV gene in tumor tissues and a number of parameters including age, histological tumor grade and tubule formation. Taken together, the current study shows dysregulation of a number of RHOA-related lncRNAs in breast cancer in association with abnormal up-regulation of this member of Rho GTPase family and suggests conduction of additional functional studies to unravel their mode of participation in the breast carcinogenesis.
Insights
This study reveals that specific long non-coding RNAs (lncRNAs) like NORAD and NRAV are significantly elevated in breast cancer tissues, correlating with increased RHOA expression. These findings highlight the role of lncRNAs in breast cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Rho GTPases are crucial for cell functions like migration and cell cycle progression.
- Aberrant Rho GTPase activity and expression are implicated in various cancers, including breast cancer.
- Long non-coding RNAs (lncRNAs) can modulate Rho GTPase activity, influencing cancer development.
Purpose of the Study:
- To investigate the expression levels of four Rho GTPase-related lncRNAs (NORAD, RAD51-AS1, NRAV, and DANCR) in breast cancer tissues compared to non-cancerous tissues.
- To explore the relationship between the expression of these lncRNAs and the expression of RHOA, a key Rho GTPase.
- To identify potential correlations between lncRNA expression and clinical parameters in breast cancer patients.
Main Methods:
- Quantitative analysis of lncRNA and RHOA expression in paired tumor and non-tumor breast tissue samples.
- Statistical analysis to determine expression ratios, significance (P-values), and confidence intervals.
- Correlation analysis between lncRNA expression and clinicopathological features such as age, tumor grade, and tubule formation.
Main Results:
- NORAD and NRAV expression levels were significantly higher in breast cancer tissues compared to non-tumoral tissues (P < 0.0001 and P = 0.0013, respectively).
- RHOA expression was also significantly up-regulated in malignant tissues (P < 0.0001).
- RAD51-AS1 and DANCR showed a trend towards up-regulation, but did not reach statistical significance (P = 0.0706 and P = 0.3746, respectively).
- NRAV expression correlated significantly with patient age, histological tumor grade, and tubule formation.
Conclusions:
- The study demonstrates the dysregulation of specific RHOA-related lncRNAs in breast cancer.
- Elevated expression of NORAD and NRAV, along with RHOA, suggests their involvement in breast carcinogenesis.
- Further functional studies are warranted to elucidate the precise mechanisms by which these lncRNAs contribute to breast cancer progression.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Nucleolus
The Ras Gene
Ras is a...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
MicroRNAs